[What are the aims and targets of renal anemia therapy?].
Eckardt
K-U
KU
Medizinische Klinik 4, Schwerpunkt Nephrologie und Hypertensiologie, Universitätsklinikum Erlangen und Klinikum Nürnberg, Germany. med4@rzmail.uni-erlangen.de
D000740:Anemia / Q000209:etiology* / Q000401:mortality / Q000628:therapy*; D002318:Cardiovascular Diseases / Q000209:etiology; D002908:Chronic Disease; D004921:Erythropoietin / Q000031:analogs & derivatives / Q000096:biosynthesis / Q000172:deficiency* / Q000235:genetics / Q000627:therapeutic use*; D005260:Female; D015870:Gene Expression; D005919:Glomerular Filtration Rate / Q000502:physiology; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007501:Iron / Q000008:administration & dosage; D007674:Kidney Diseases / Q000150:complications* / Q000401:mortality / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D008297:Male; D011379:Prognosis; D011788:Quality of Life; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects; D012307:Risk Factors
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D007501:Iron